Effects of steroids in focal segmental glomerulosclerosis in a predominantly African-American population

American Journal of the Medical Sciences

Volumn 330, Issue 1, 2005, Pages 19-24

  Crook, Errol D ^a,b   Habeeb, Daniel ^a   Gowdy, Otis ^a   Nimmagadda, Santhi ^b   Salem, Mahmoud ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African American; Angiotensin converting enzyme inhibitor; Blood pressure; Corticosteroids (prednisone); End stage renal disease; Focal segmental glomerulosclerosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CORTICOSTEROID; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PREDNISONE;

ADULT; AFRICAN AMERICAN; BLOOD PRESSURE; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOCAL SEGMENTAL GLOMERULONEPHRITIS; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PROTEIN URINE LEVEL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY; REVIEW; WEIGHT GAIN;

EID: 22344442265     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200507000-00004     Document Type: Article

References (23)

1. Tucker JK. Focal segmental glomerulosclerosis in African Americans. Am J Med Sci 2002;323:90-3.
2. Haas M, Spargo BH, Coventry S. Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study. Am J Kidney Dis 1995;5:740-50.
3. Braden GL, Mulhern JG, O'Shea MH, et al. Changing incidence of glomerular diseases in adults. Am J Kidney Dis 2000;35:878-83.
4. Korbet SM. Disease of the month: primary focal segmental glomerulosclerosis: pathology, histologic variants, and pathogenesis. Am J Kidney Dis 1993;22:874-83.
5. Banfi G, Moriggi M, Sabadini E, et al. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults: a collaborative retrospective study. Clin Nephrol 1991;36:53-9.
6. Rydel J, Korbet S, Borok R, et al. Focal segmental glomerulosclerosis in adults: presentation, course, and response to treatment. Am J Kidney Dis 1995;25:534-42.
7. Crenshaw G, Bigler S, Salem M, et al. Focal segmental glomerulosclerosis in African Americans: effects of steroids and angiotensin converting enzyme inhibitors. Am J Med Sci 2000;319:320-5.
8. Ingulli E, Tejani A. Racial differences in the incidence and renal outcomes of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 1991;5:393-7.
9. Wehrmann M, Bohle A, Held H, et al. Long-term prognosis of focal segmental glomerulosclerosis: an analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol 1990;33:115-22.
10. Hayslett JP, Krassner LS, Bensch KG, et al. Progression of "lipoid nephrosis" to renal insufficiency. N Engl J Med 1969;281:181-7.
11. Burgess E. Management of focal segmental glomerulosclerosis: evidence-based recommendations. Kidney Int 1999;55(Suppl 70):S26-S32.
12. Matalon A, Valeri A, Appel GB. Treatment of focal segmental glomerulosclerosis. Semin Nephrol 2000;20:309-17.
13. Meyrier A. Treatment of primary focal segmental glomerulosclerosis. Nephrol Dial Transplant 1999;14(Suppl 3):74-8.
14. Pei Y, Cattran D, Delmore T, et al. Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Am J Med 1987;82:938-44.
15. Velosa J, Holley K, Torres V, et al. Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis. Mayo Clin Proc 1983;58:568-77.
16. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997;349:1857-63.
17. Maschio G, Albert D, Janin G, et al. Effect of the angiotensin- converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996;334:939-45.
18. Bakir AA, Share DS, Levy PS, et al. Focal segmental glomerulosclerosis in African-Americans. Clin Nephrol 1996;46:306-11.
19. Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001;59:1498-509.
20. Praga M, Hernandez E, Morales E, et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant 2001;16:1790-8.
21. Korbet SM, Genchi R, Borok RZ, et al. The racial prevalence of glomerular lesions in nephrotic adults. Am J Kidney Dis 1996;5:647-51.
22. Detwiler RK, Falk RJ, Hogan SL, et al. Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 1994;45:1416-24.
23. Chun MJ, Korbet SM, Schwartz MM, et al. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 2004;15:2169-77.